Qatar Health

Displaying 37 - 42 of 51
Rising demand for health care combined with the graduated introduction of the National Health Insurance Scheme (Seha) look set to boost Qatar’s nascent pharmaceuticals and medical products segment.

2013 saw the transition of power from the former Emir, Sheikh Hamad bin Khalifa Al Thani, to Sheikh Tamim bin Hamad Al Thani, his fourth son and second son with Sheikha Moza bint Nasser, a move unprecedented elsewhere in the Gulf but not unexpected in Qatar. 

Qatar’s health care sector is undergoing vigorous change, for both good and bad reasons. The good news is that Qataris are living longer. The bad is that more are living with lifestyle-related chronic diseases such as diabetes, heart disease and cancer. To meet this challenge, the government has been making sizeable investments in health care:...

How is the SCH working to combat the incidence of lifestyle-related diseases in Qatar?

One beneficiary of the roll-out of Qatar’s new national health service will be the pharmaceutical industry. As part of the new health care system, the Supreme Council of Health (SCH) is leading an effort to promote generic drugs in partnership with Hamad Medical Corporation (HMC), the Primary Health Care Corporation (PHCC) and other providers....

Chapter | Health from The Report: Qatar 2014

Qatar’s health care sector is undergoing vigorous change, for both good and bad reasons. The good news is that Qataris are living longer. The bad is that more are living with lifestyle-related chronic diseases such as diabetes, heart disease and cancer. To meet this challenge, the government has been making sizeable investments in health care: Qatar now spends more per capita on health than any...

Covid-19 Economic Impact Assessments

Stay updated on how some of the world’s most promising markets are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues.

Register now and also receive a complimentary 2-month licence to the OBG Research Terminal.

Register Here×